The U.S. House of Representatives is considering dueling proposals related to drug pricing under Medicaid and Medicare, including the Republican-led H.R. 19, the “Lower Costs, More Cures Act of 2021” and a reintroduced...more
4/26/2021
/ Biden Administration ,
Critical Infrastructure Sectors ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Healthcare Reform ,
Legislative Agendas ,
Medicaid ,
Medicaid Drug Rebate Program ,
Medicare ,
Medicare Part D ,
Patient Access ,
Pharmaceutical Industry ,
Prescription Drugs ,
Regulatory Agenda
On March 17, 2021, the Centers for Medicare & Medicaid Services (CMS) published a notice in the Federal Register delaying the effective date of the final rule titled, “Medicare Program; Medicare Coverage of Innovative...more
On November 20, 2020, the U.S. Centers for Medicare & Medicaid Services (CMS) issued an interim final rule (IFR) with comment period implementing a mandatory “Most Favored Nation” demonstration model (MFN Model) to test...more
11/24/2020
/ Biologics ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Drug Pricing ,
Health Insurance ,
Healthcare Reform ,
Interim Final Rules (IFR) ,
Medicare Part B ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Prescription Drug Coverage ,
Reimbursements
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time. ...more
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time....more
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time....more
6/9/2020
/ AFMPS ,
Center for Drug Evaluation and Research (CDER) ,
CGMP ,
Coronavirus/COVID-19 ,
Enforcement Guidance ,
European Medicines Agency (EMA) ,
Food and Drug Administration (FDA) ,
Intellectual Property Protection ,
Life Sciences ,
Marketing Authorization Application ,
Medical Devices ,
Pharmaceutical Industry
The Daily Report is a compilation of COVID-19 (coronavirus) news briefs from around the world to help life sciences and health care companies stay current in this challenging time.
...more
4/27/2020
/ Belgium ,
CARES Act ,
Coronavirus/COVID-19 ,
Federal Loans ,
Food and Drug Administration (FDA) ,
Judicial Proceedings ,
Life Sciences ,
Medical Devices ,
Medical Supplies ,
Paycheck Protection Program (PPP) ,
Personal Protective Equipment ,
Pharmaceutical Industry ,
Publicly-Traded Companies ,
Re-Opening Guidelines ,
Relief Measures ,
Supply Chain ,
Tax Relief